Toubani Resources Inc (ASX:TRE, OTC:AGGFF) has its sights set on an optimised definitive feasibility study (DFS) for the 3.1-million-ounce Kobada Gold Project in southern Mali.
The company is on a mission to develop West Africa’s next major gold mine, underpinned by a substantial initial oxide mining operation.
Ioneer Ltd (ASX:INR, OTC:GSCCF, NASDAQ:IONR), an emerging lithium-boron supplier, has renewed the employment agreement for executive chairman James D Calaway for a further 12-month period, effective July 1, 2023.
Calaway was appointed executive chairman in July 2020 after serving as chair in a non-executive capacity since 2017.
US officials have granted full approval to Leqembi, the first medication to demonstrate modest effectiveness in slowing cognitive decline associated with Alzheimer’s disease.
Developed by Japanese drug-maker Eisai and comarketed with Biogen Inc (NASDAQ:BIIB), the American pharmaceutical giant, the FDA's endorsement paves the way for Medicare and other insurance plans to cover the treatment for individuals with mild dementia and early symptoms of Alzheimer's disease.
BioVie Inc (NASDAQ:BIVI) announced that a poster detailing how its drug candidate NE3107 regulated specific genes in a way significantly correlated with observed cognitive and biomarker improvements will be presented at the Alzheimer’s Associate’s International Conference being held in Amsterdam this weekend from July 16 to 20.
The news sent BioVie's stock higher, with it up 5.4% at US$4.68 at Monday's close
Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF) shares soared higher in Monday’s trading as the explorer seized control of its own drilling destiny in Tanzania, as it opted to acquire its own drill rig rather than see its timeline stall without a contractor.
The company expects to start drilling a well at the Tai project before the end of the third quarter, thanks to the deal.
Atossa Therapeutics Inc (NASDAQ:ATOS) announced that 170 patients have been enrolled across its ongoing Phase 2 Karisma-Endoxifen study of its oral formulation of (Z)-endoxifen in premenopausal women with measurable breast density.
The company said it expects the trial to be fully enrolled in the fourth quarter of 2023.
Gratomic Inc. (TSX-V:GRAT, OTCQX:CBULF) has announced the appointments of Bruno Baillavoine as executive chair of its board of directors and Stephen Woodhead as its chief financial officer (CFO).
The company said Woodhead, who has served as Gratomic’s executive vice president, finance, since March 2021, will fill the vacancy created by the retirement of Rodger Roden.
Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has announced that it will be changing its corporate name to Predictmedix AI Inc, aligning the company's brand image with its innovative and AI-driven approach to revolutionizing various aspects of healthcare and safety.
The decision to incorporate ‘AI’ into the company's name highlights Predictmedix's commitment to "utilizing cutting-edge artificial intelligence technologies to enhance healthcare diagnostics, screening, workplace safety, impairment detection, and fitness screening".
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) has told investors it is tightening its focus on two critical assets, SCIB1 and Modi-1, following promising results from ongoing trials.
“With SCIB1 we have a clear potential development pathway towards the market, and Modi-1 is demonstrating an effect on disease control in ovarian cancer patients,” Scancell chief executive Lindy Durrant said in a statement.
Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF) told investors that it fully expects to deliver a production test of the State 36-2 LNW-CC well at the Paradox project in Utah in the near-term.
The company today provided an update on the well which suffered a “well control incident” earlier this year amid higher-than-anticipated well pressures which triggered equipment failures and damaged production tubing.
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) said ongoing underground drilling at the Blanket Mine in Zimbabwe indicated that the Eroica target ore body continues at depth with better widths and higher grades than expected.
The miner drilled 5,600 metres (m) between January 2023 and the end of May with a further 12,900m planned for the remainder of 2023.
Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF) told investors it has now secured an alternate drill rig for its proposed Tai-C well programme in Tanzania, which is still slated for the third quarter of 2023.
The exploration company, in a statement, said it has acquired an Epiroc Predator 220 drilling rig - an oil and gas type rig capable of drilling to depths in excess of 2,000 metres – which is already in Tanzania and is being mobilised to Helium One’s Rukwa project.
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has successfully dosed its first cohort of both male and female subjects with RECCE 327 (R327) as part of its Phase I/II UTI (urinary tract infection) clinical trial, with no serious adverse events reported.
The cohort were all dosed at two faster infusion rates of 2,500mg and included the first female to receive R327 via I.V. administration – more rapid than that used in Recce’s completed 80-subject Phase I study.
Alkane Resources Ltd (ASX:ALK) is shoring up regional prospects at the Tomingley gold camp in Central West New South Wales as it crafts a roadmap for future mining operations.
The precious metals stock uncovered gold at several regional prospects within seven kilometres of its Tomingley processing hub soon after regional drilling kicked off in early 2023.
Silver X Mining Corp said it has closed the third and final tranche of its previously announced non-brokered private placement offering with the placement of a total of 8,600,750 units for aggregate gross proceeds of $2,580,225. Under the third and final tranche, the company sold an additional 1,384,000 Units at a price of $0.30 per unit for additional gross proceeds of $415,200. On June 5, 2023, the company announced the closing of the first tranche of the offering with proceeds of $1,263,015 and on June 28, 2023, the company announced the closing of the second tranche of the Offering with proceeds of $902,010. The company intends to use the net proceeds from the offering for capital expenditures and exploration related to the Nueva Recuperada Silver District in Peru and potential acquisitions of assets.
Bioharvest Sciences Inc said it has arranged a non-brokered private placement of convertible notes for proceeds of $4,625,102.87. The funds raised will predominantly support the company's growth in its polyphenols/antioxidants vertical. The funds will also support the research and development program for potentially providing APIs to the pharmaceutical industry on the basis of its botanical compositions. The convertible notes are denoted in Canadian dollars, have a 12-month term and pay interest of 9% per annum. The convertible notes are convertible as to principal and accrued interest at the option of the holder into common shares of the company at a conversion price of 20 cents per share.
Auxico Resources Canada Inc said it has granted 2.7 million stock options to officers, directors and consultants to the company. These options have a strike price of 30 cents, no vesting period and an expiry date of July 6, 2028.
Phunware Inc said it made an inducement grant to Troy Reisner in connection with his employment as Phunware’s new chief financial officer, effective June 2, 2023. The company’s board has granted Reisner an aggregate of 600,000 restricted stock units (RSUs) under the inducement plan. The grant was included in Reisner’s employment agreement. The restricted stock units granted are subject to a vesting schedule commencing on June 2, 2023, with one-third of the RSUs vesting on the first anniversary of the commencement date, and the remaining amount vesting in equal annual installments thereafter, subject to Reisner’s continued employment.
MTB Metals Corp said it has retained Simone Capital Corp in the capacity of Investor Relations and Capital Markets Advisory. Simone Capital will be paid C$13,000 per quarter and granted 400,000 options. The term for this agreement is three months with an automatic extension for three additional three-month terms subject to termination on a 30 days' notice. The options granted to Simone Capital are exercisable at $0.12 per share for a five year term. The options will vest as to one quarter at the end of each three month period commencing October 7, 2023. The company also announced the grant of stock options to directors, employees, advisors and consultants for an aggregate of 1,560,000 shares at an exercise price of $0.12 for a term of 5 years. In addition, MTB has granted Restricted Share Units (RSUs) to directors, employees, advisors and consultants for an aggregate of 2,825,000 shares. The RSUs will vest after 12 months.
Aurion Resources Ltd said it has amended and closed the option agreement with Dragon Mining Ltd to acquire and eliminate all encumbrances on the Kutuvuoma and Silasselkä projects, as disclosed in the news release dated May 31, 2023. The company has issued to Dragon 37,500 common shares of Aurion as consideration for the grant of the option. The agreement has been amended to provide that the number of consideration shares that may be issued to Dragon under the agreement will not result in Dragon owning, or having control or direction over, more than 9.9% of the then-issued shares of Aurion. Should the payment result in the potential for that occurring, the balance of the applicable payment will be made in cash.
American Resources Corporation vice president corporate finance and communications Mark LaVerghetta will participate in the Virtual Investor Summer Spotlight Series on July 12, 2023, at 2:00 PM ET. A live video webcast of the presentation will be accessible on the Events section of the Investors page on American Resources Corporation's website (www.americanresourcescorp.com). Additionally, a replay of the webcast will be available two hours after the live presentation concludes and will remain accessible for 90 days.
Banxa Holdings Inc said its management team will be hosting an investor webinar on July 12, 2023, at 11 am ET/8 am PT to provide business updates and address any questions from investors. Chairman Domenic Carosa, CEO Holger Arians, and Chief Product Officer Tom Chalmers will be leading the presentation. The webinar offers an opportunity for stakeholders to gain insights into the company's current activities and engage directly with its leadership. Register here: https://bit.ly/BNXA-Webinar